id: NEW:nonalcoholic_steatohepatitis_nash_to_NEW:hepatocellular_carcinoma_hcc
name: Nonalcoholic Steatohepatitis (NASH) â†’ Hepatocellular Carcinoma (HCC)
from_node:
  node_id: NEW:nonalcoholic_steatohepatitis_nash
  node_name: Nonalcoholic Steatohepatitis (NASH)
to_node:
  node_id: NEW:hepatocellular_carcinoma_hcc
  node_name: Hepatocellular Carcinoma (HCC)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: NASH causes chronic liver inflammation with hepatocyte injury, leading
  to cycles of cell death and regeneration'
- 'Step 2: Repeated hepatocyte turnover and oxidative stress promote accumulation
  of genetic mutations in liver progenitor cells'
- 'Step 3: Progressive fibrosis develops in most cases, creating a pro-tumorigenic
  microenvironment, though HCC can arise even without significant fibrosis in up to
  38% of NASH-HCC cases'
- 'Step 4: Metabolic dysfunction associated with NASH (insulin resistance, lipotoxicity,
  altered adipokine signaling) provides additional carcinogenic stimulus independent
  of cirrhosis'
- 'Step 5: Malignant transformation of HCC precursor cells leads to hepatocellular
  carcinoma initiation and progression'
evidence:
  quality_rating: B
  n_studies: 19
  primary_citation: 'Renumathy Dhanasekaran and Dean W Felsher 2019. A Tale of Two
    Complications of Obesity: NASH and Hepatocellular Carcinoma. Hepatology (Baltimore,
    Md.)'
  supporting_citations: []
description: NASH promotes hepatocellular carcinoma through chronic inflammation,
  repeated hepatocyte injury and regeneration cycles, and progressive fibrosis. Unlike
  other chronic liver diseases where cirrhosis almost always precedes HCC, NASH can
  lead to HCC even without significant fibrosis in a substantial proportion of cases
  (up to 38%), suggesting additional obesity-related metabolic mechanisms contribute
  to carcinogenesis.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 38.0
    type: prevalence_percentage
    ci_lower: null
    ci_upper: null
  p_value: null
  sample_size: null
moderators:
- name: Cirrhosis status
  direction: strengthens
  strength: moderate
  description: While cirrhosis precedes HCC in >90% of patients with other chronic
    liver diseases (hepatitis C, alcohol), up to 38% of NASH-HCC cases occur without
    significant underlying fibrosis
- name: Obesity
  direction: strengthens
  strength: moderate
  description: Obesity may contribute to HCC pathogenesis independent of NASH and
    overt fibrosis/cirrhosis through additional metabolic mechanisms
